The Financial Times - Global Pharmaceutical and Biotechnology Conference 2019

Event Details

Start Date
Mon, 11 Nov
End Date
Tue, 12 Nov
Location
London
Share This Page
Attending

Disruption and transformation will continue to be the focus of life science leaders in 2019 and beyond.

Pricing pressures in the US and a growing number of markets globally has already set in motion a search for new and innovative payment models, while the rise of ultra-expensive, potentially curative gene and cell therapies has brought to the fore a heated discussion about the sustainability of industry’s underlying economic and funding model.

With a host of new entrants’ in the shape of big tech and nimble, consumer-centric start-ups nibbling at pharma’s heals in the emerging prevention and wellness space, meanwhile, pharma faces competition on an increasing number of fronts. Success in the new data and patient-centric world which is emerging will increasingly depend on the forging relationships with patients sustained on trust, and building new business models for the future.

FT Live has a reputation for delivering very senior board level audiences to attend a wide range of world class thought-leadership events across the globe for nearly 40 years.

The FT Global Pharmaceutical and Biotechnology Conference will be attended by:

  • Pharmaceutical companies
  • Biotechnology companies
  • Diagnostic and medical device
  • CROs
  • Healthcare providers and insurers
  • Government healthcare departments, HTA’s and drug regulators
  • IT, big data and analytics providers
  • Health economists
  • Healthcare investment bankers, private equity
  • Patient representatives and NGOs